It’s not easy to make good food choices when there’s a takeaway on every corner.
Articles on NICE
Displaying 21 - 28 of 28 articles
The cost of cancer drugs is killing patients and it needs to stop
NICE recommends psychotherapy for treating schizophrenia and bipolar disorder,
despite a lack of high quality evidence to show that they’re effective.
There are pros and cons to HRT. Whether or not to use it comes down to personal choice.
Hope, fear, and desperation, along with the unique characteristics of the cancer drug market, create a “perfect storm” that continues to drive up prices for cancer drugs.
The National Institute for Health and Care Excellence (NICE) has published new draft proposals laying out major changes to the way it assesses whether new medicines offer value for money for the NHS. These…
Demonstrating her considerable skills as a teacher, in a recent lecture at the University of Birmingham, Estelle Morris posed a question that reminded her audience of the start of a children’s book. “Where…
The continuing shortfall of organs available for transplantation has recently prompted a radical rethink of current end-of-life practices in the United Kingdom. The British Medical Association (BMA) has…
Top contributors
-
Honorary Fellow, Department of Health Sciences, University of York
-
Associate Professor in Cellular and Molecular Sciences, Northumbria University, Newcastle
-
Professor of epidemiology, University of Oxford
-
Associate professor, Queensland University of Technology
-
Research Fellow, Health Economics, Glasgow Caledonian University
-
Senior Investigator Scientist, University of Cambridge
-
Professor of Bioethics & Medicine, Sydney Health Ethics, Haematologist/BMT Physician, Royal North Shore Hospital and Director, Praxis Australia, University of Sydney
-
Professor of Bioethics, Macquarie University
-
Career Development Fellow (Post-doctoral Research Associate), University of Cambridge
-
Senior lecturer in Immunology, University of Exeter
-
Senior Research Fellow at Veterans and Families Institute, Anglia Ruskin University
-
Professor, Washington State University
-
Professor of Molecular Oncology, University of Bradford
-
Professor of Health Economics, Glasgow Caledonian University
-
School of Social Sciences, Nottingham Trent University